Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Syphilis Testing Market, by Type
1.4.2 Europe Syphilis Testing Market, by Location of Testing
1.4.3 Europe Syphilis Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Syphilis Testing Market by Type
3.1 Europe Primary & Secondary Syphilis Market by Country
3.2 Europe Others Market by Country
Chapter 4. Europe Syphilis Testing Market by Location of Testing
4.1 Europe Laboratory testing Market by Country
4.2 Europe Point of care (POC) testing Market by Country
Chapter 5. Europe Syphilis Testing Market by Country
5.1 Germany Syphilis Testing Market
5.1.1 Germany Syphilis Testing Market by Type
5.1.2 Germany Syphilis Testing Market by Location of Testing
5.2 UK Syphilis Testing Market
5.2.1 UK Syphilis Testing Market by Type
5.2.2 UK Syphilis Testing Market by Location of Testing
5.3 France Syphilis Testing Market
5.3.1 France Syphilis Testing Market by Type
5.3.2 France Syphilis Testing Market by Location of Testing
5.4 Russia Syphilis Testing Market
5.4.1 Russia Syphilis Testing Market by Type
5.4.2 Russia Syphilis Testing Market by Location of Testing
5.5 Spain Syphilis Testing Market
5.5.1 Spain Syphilis Testing Market by Type
5.5.2 Spain Syphilis Testing Market by Location of Testing
5.6 Italy Syphilis Testing Market
5.6.1 Italy Syphilis Testing Market by Type
5.6.2 Italy Syphilis Testing Market by Location of Testing
5.7 Rest of Europe Syphilis Testing Market
5.7.1 Rest of Europe Syphilis Testing Market by Type
5.7.2 Rest of Europe Syphilis Testing Market by Location of Testing
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Danaher Corporation (Cepheid)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Becton, Dickinson and Company
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Thermo Fisher Scientific, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Bio-Rad laboratories, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expenses
6.6 Hologic, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent Strategies and Developments:
6.6.5.1 Approvals and Trials:
6.7 DiaSorin S.p.A. (Luminex Corporation)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expenses
6.8 Abbott Laboratories
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent Strategies and Developments:
6.8.5.1 Approvals and Trials:
6.9 Siemens Healthineers AG (Siemens AG)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
Unique Offerings 